Penn Medicine Provider
Diabetes, Endocrinology
Mona Al Mukaddam, MD, MS
4.9
(363)
Sees patients age 18 and up
Penn Endocrinology and Diabetes University City
Make an appointmentCall 215-662-9905

About me

  • Director, Penn Bone Center
  • Associate Professor of Clinical Medicine (Endocrinology, Diabetes and Metabolism)
  • Associate Professor of Medicine in Orthopaedic Surgery

Education and training

  • Medical School: American University of Beirut
  • Residency: American University of Beirut Medical Center
  • Residency: University of Iowa Hospitals and Clinics
  • Fellowship: Hospital of the University of Pennsylvania

What my patients think about me

Average Rating
4.9

364 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

June 2025
5.0
5.0
the doctor explained every part of the surgery and why i have to have surgery.
June 2025
5.0
5.0
on a yearly basis, she has been an exemplary physician.
June 2025
5.0
5.0
dr. accommodated my request for closest possible infusion location to my home, pointed out another condition she noticed that was unrelated to diagnosis being addressed today.
June 2025
5.0
5.0
dr. mona's expertise; assessment and treatment options explained, she answered all questions.

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Al Mukaddam is a Penn Medicine physician.

Qualifications and experience

My research

Cassandra Crompton, PharmD; Kassidy Baum, PharmD; Michael Silvey, PharmD; Mona Al Mukaddam, MD, MS Comparison of Forteo® and Teriparatide on Improvements in Bone Mineral Density , Poster Presentation at Endocrine Society Annual Meeting : 2025

Javier Ocampo Mascaro, Katherine Toder, Staci Kallish, Mona Al Mukaddam Applying the Hypophosphatasia Diagnostic Criteria in a Patient Cohort at the Penn Bone Center , Post Presentation at Endocrine Society Annual Meeting: 2025

Bassam AlHamer and Mona Al Mukaddam Silicosis Induced Hypercalcemia Treated with Ketoconazole , Post Presentation at Endocrine Society Annual Meeting: 2025

Natalie Dapas, Mona Al Mukaddam, Hamdee Attallah, Carrie M. Burns, Robert Jones, Julia Kharlip, Kristen Noelle Kobaly, Serena Cardillo Creation of Educational Resources to Improve Endocrine Fellow Outpatient Curriculum , Poster Presentation at Endocrine Society Annual Meeting: 2025

Vincent A. Verheij, Robert J. Diecidue, Esmée Botman, Joseph D. Harrington, Nobuhiko Haga, Alberto Hidalgo-Bravo, Patricia L. R. Delai, Vrisha Madhuri, Mona Al Mukaddam, Keqin Zhang, Tae-Joon Cho, Rolf Morhart, Richard Keen, Carmen L. De Cunto, Clive S. Friedman, Zvi Grunwald, Michael Zasloff, J. Coen Netelenbos, Edward Hsiao, Frederick S. Kaplan, Robert J. Pignolo, Christiaan Scott and Elisabeth Marelise W. Eekhoff Palovarotene in fibrodysplasia ossificans progressiva: review and perspective , Expert Opinion on Pharmacotherapy : 2025

Edward C. Hsia, Robert J. Pignolo, Mona Al Mukaddam, Geneviève Baujat, Staffan K. Berglund, Angela M. Cheung, Carmen De Cunto, Patricia Delai, Peter Kannu, Richard Keen, Edna E. Mancilla, Fei Shih, Andrew Strahs and Frederick S. Kaplan The Impact of Palovarotene Treatment on Heterotopic Ossification in Patients with Fibrodysplasia Ossificans Progressiva With and Without Flare-Ups: Data from the Phase III MOVE Trial and Natural History Study , Poster presentation ASBMR annual meeting, Toronto, CA: 2024

Tarun Mattikalli, Rashad Madi, Steven Graham, Julio Ojea Quintana, Hannah Rosenblatt, Bruce J. Kneeland, Amna Nabeel Khan, Benjamin T. Newman, Elena Taratuta, Mona Al Mukaddam, Chamith S. Rajapakse Using Machine Learning Algorithms for High-Risk Patient Identification in Atypical Femoral Fractures , Poster presentation ASBMR annual meeting, Toronto, CA: 2024

Keen R, Dahir KM, McGinniss J, Sanchez RJ, Mellis S, Economides AN, Di Rocco M, Orcel P, Roux C, Tabarkiewicz J, Bachiller-Corral J, Cheung AM, Al Mukaddam M, Mohammadi K, Gu J, Srinivasan D, Trotter DG, Eekhoff EMW, Kaplan FS, Pignolo RJ. Characterization of flare-ups and impact of Garetosmab in adults with Fibrodysplasia Ossificans Progressiva: a post hoc analysis of the randomized, double-blind, placebo-controlled LUMINA-1 trial. , J Bone Miner Res, 26(39): 2024,1486-1492

Patricia Delai, Mona Al Mukaddam, Geneviève Baujat, Carmen De Cunto, Edward C. Hsiao, Richard Keen, Kim Croskery, Jean-Luc Delhay, Christelle Pommie, Robert J. Pignolo Incidence and management of skin adverse events in patients receiving palovarotene for the treatment of fibrodysplasia ossificans progressiva , Poster Presentation at ICCBH Salzburg, Austria: 2024

Edna E. Mancilla, Geneviève Baujat, Mona Al Mukaddam, Javier Bachiller-Corral, Staffan K. Berglund, Carmen De Cunto, Patricia Delai, Richard Keen, Riccardo Papa, Robert J. Pignolo, Sally Lanar, Alexia Marrel, Alexander Artyomenko, Kim Croskery, Christelle Pommie, Edward C. Hsiao The impact of palovarotene on patients with fibrodysplasia ossificans progressiva: Results from participant interviews in the phase III PIVOINE trial. , Oral Presentation at ICCBH Salzburg, Austria : 2024